224 related articles for article (PubMed ID: 36189922)
1. S6K1 phosphorylates Cdk1 and MSH6 to regulate DNA repair.
Amar-Schwartz A; Ben Hur V; Jbara A; Cohen Y; Barnabas GD; Arbib E; Siegfried Z; Mashahreh B; Hassouna F; Shilo A; Abu-Odeh M; Berger M; Wiener R; Aqeilan R; Geiger T; Karni R
Elife; 2022 Oct; 11():. PubMed ID: 36189922
[TBL] [Abstract][Full Text] [Related]
2. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Julien LA; Carriere A; Moreau J; Roux PP
Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
[TBL] [Abstract][Full Text] [Related]
3. Trastuzumab stimulation of ribosomal protein S6 kinase 1 (S6K1) predicts de novo trastuzumab resistance.
Huynh FC; Nguyen D; Jones FE
Biochem Biophys Res Commun; 2017 Jan; 483(1):739-744. PubMed ID: 27993682
[TBL] [Abstract][Full Text] [Related]
4. S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1.
Ben-Hur V; Denichenko P; Siegfried Z; Maimon A; Krainer A; Davidson B; Karni R
Cell Rep; 2013 Jan; 3(1):103-15. PubMed ID: 23273915
[TBL] [Abstract][Full Text] [Related]
5. The role of S6K1 in ER-positive breast cancer.
Holz MK
Cell Cycle; 2012 Sep; 11(17):3159-65. PubMed ID: 22895181
[TBL] [Abstract][Full Text] [Related]
6. Direct imaging of the recruitment and phosphorylation of S6K1 in the mTORC1 pathway in living cells.
Ahmed AR; Owens RJ; Stubbs CD; Parker AW; Hitchman R; Yadav RB; Dumoux M; Hawes C; Botchway SW
Sci Rep; 2019 Mar; 9(1):3408. PubMed ID: 30833605
[TBL] [Abstract][Full Text] [Related]
7. The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation.
Csibi A; Lee G; Yoon SO; Tong H; Ilter D; Elia I; Fendt SM; Roberts TM; Blenis J
Curr Biol; 2014 Oct; 24(19):2274-80. PubMed ID: 25220053
[TBL] [Abstract][Full Text] [Related]
8. Multisite Phosphorylation of S6K1 Directs a Kinase Phospho-code that Determines Substrate Selection.
Arif A; Jia J; Willard B; Li X; Fox PL
Mol Cell; 2019 Feb; 73(3):446-457.e6. PubMed ID: 30612880
[TBL] [Abstract][Full Text] [Related]
9. Elevated protein kinase D3 (PKD3) expression supports proliferation of triple-negative breast cancer cells and contributes to mTORC1-S6K1 pathway activation.
Huck B; Duss S; Hausser A; Olayioye MA
J Biol Chem; 2014 Feb; 289(6):3138-47. PubMed ID: 24337579
[TBL] [Abstract][Full Text] [Related]
10. Small molecule H89 renders the phosphorylation of S6K1 and AKT resistant to mTOR inhibitors.
Melick CH; Jewell JL
Biochem J; 2020 May; 477(10):1847-1863. PubMed ID: 32347294
[TBL] [Abstract][Full Text] [Related]
11. Insulin potentiates essential amino acids effects on mechanistic target of rapamycin complex 1 signaling in MAC-T cells.
Pszczolkowski VL; Zhang J; Pignato KA; Meyer EJ; Kurth MM; Lin A; Arriola Apelo SI
J Dairy Sci; 2020 Dec; 103(12):11988-12002. PubMed ID: 33222863
[TBL] [Abstract][Full Text] [Related]
12. Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
Zhao MY; Auerbach A; D'Costa AM; Rapoport AP; Burger AM; Sausville EA; Stass SA; Jiang F; Sands AM; Aguilera N; Zhao XF
Clin Cancer Res; 2009 Mar; 15(5):1708-20. PubMed ID: 19223503
[TBL] [Abstract][Full Text] [Related]
13. Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.
Karlsson E; Magić I; Bostner J; Dyrager C; Lysholm F; Hallbeck AL; Stål O; Lundström P
PLoS One; 2015; 10(12):e0145013. PubMed ID: 26698305
[TBL] [Abstract][Full Text] [Related]
14. Regulation of CHK1 by mTOR contributes to the evasion of DNA damage barrier of cancer cells.
Zhou X; Liu W; Hu X; Dorrance A; Garzon R; Houghton PJ; Shen C
Sci Rep; 2017 May; 7(1):1535. PubMed ID: 28484242
[TBL] [Abstract][Full Text] [Related]
15. Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer.
Sridharan S; Basu A
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054043
[TBL] [Abstract][Full Text] [Related]
16. Mitotic regulation of ribosomal S6 kinase 1 involves Ser/Thr, Pro phosphorylation of consensus and non-consensus sites by Cdc2.
Shah OJ; Ghosh S; Hunter T
J Biol Chem; 2003 May; 278(18):16433-42. PubMed ID: 12586835
[TBL] [Abstract][Full Text] [Related]
17. The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168.
Xie X; Hu H; Tong X; Li L; Liu X; Chen M; Yuan H; Xie X; Li Q; Zhang Y; Ouyang H; Wei M; Huang J; Liu P; Gan W; Liu Y; Xie A; Kuai X; Chirn GW; Zhou H; Zeng R; Hu R; Qin J; Meng FL; Wei W; Ji H; Gao D
Nat Cell Biol; 2018 Mar; 20(3):320-331. PubMed ID: 29403037
[TBL] [Abstract][Full Text] [Related]
18. mTOR pathway and DNA damage response: A therapeutic strategy in cancer therapy.
Danesh Pazhooh R; Rahnamay Farnood P; Asemi Z; Mirsafaei L; Yousefi B; Mirzaei H
DNA Repair (Amst); 2021 Aug; 104():103142. PubMed ID: 34102579
[TBL] [Abstract][Full Text] [Related]
19. p53/TAp63 and AKT regulate mammalian target of rapamycin complex 1 (mTORC1) signaling through two independent parallel pathways in the presence of DNA damage.
Cam M; Bid HK; Xiao L; Zambetti GP; Houghton PJ; Cam H
J Biol Chem; 2014 Feb; 289(7):4083-94. PubMed ID: 24366874
[TBL] [Abstract][Full Text] [Related]
20. PKD1 is downregulated in non-small cell lung cancer and mediates the feedback inhibition of mTORC1-S6K1 axis in response to phorbol ester.
Ni Y; Wang L; Zhang J; Pang Z; Liu Q; Du J
Int J Biochem Cell Biol; 2015 Mar; 60():34-42. PubMed ID: 25578563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
